Elsa Lilienberg

Pharmacokinetics of Total and Unbound Paclitaxel After Administration of Paclitaxel Micellar or Nab-Paclitaxel: An Open, Randomized, Cross-Over, Explorative Study in Breast Cancer Patients

Elsa Lilienberg, Helena Bjermo, Fredrik Hansson et al. · Advances in Therapy · 2019 · 48 citations · Full text

<i>In Vivo</i> Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma

Elsa Lilienberg, Ilse R. Dubbelboer, Amar Karalli et al. · Molecular Pharmaceutics · 2016 · 38 citations

Maximum Tolerated Dose and Pharmacokinetics of Paclitaxel Micellar in Patients with Recurrent Malignant Solid Tumours: A Dose-Escalation Study

Roger Henriksson, Helena Bjermo, Elsa Lilienberg et al. · Advances in Therapy · 2019 · 30 citations · Full text

Investigation of Hepatobiliary Disposition of Doxorubicin Following Intrahepatic Delivery of Different Dosage Forms

Elsa Lilienberg, Charlotte Ebeling Barbier, Rickard Nyman et al. · Molecular Pharmaceutics · 2013 · 24 citations

Local Injections, Vivo Release Rate, Oncology +15

A Model-Based Approach To Assessing the Importance of Intracellular Binding Sites in Doxorubicin Disposition

Ilse R. Dubbelboer, Elsa Lilienberg, Erik Sjögren et al. · Molecular Pharmaceutics · 2017 · 21 citations